NO20030989L - 4-halogenerte 17-metylensteroider, fremgangsmåte for fremstilling derav ogfarmasöytiske preparater som inneholder disse forbindelsene - Google Patents

4-halogenerte 17-metylensteroider, fremgangsmåte for fremstilling derav ogfarmasöytiske preparater som inneholder disse forbindelsene

Info

Publication number
NO20030989L
NO20030989L NO20030989A NO20030989A NO20030989L NO 20030989 L NO20030989 L NO 20030989L NO 20030989 A NO20030989 A NO 20030989A NO 20030989 A NO20030989 A NO 20030989A NO 20030989 L NO20030989 L NO 20030989L
Authority
NO
Norway
Prior art keywords
compounds
halogenated
preparation
pharmaceutical preparations
preparations containing
Prior art date
Application number
NO20030989A
Other languages
English (en)
Other versions
NO20030989D0 (no
NO325012B1 (no
Inventor
Bernd Menzenbach
Walter Elger
Peter Droescher
Alexander Hillisch
Guenter Kaufmann
Hans-Udo Schweikert
Gerd Mueller
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of NO20030989D0 publication Critical patent/NO20030989D0/no
Publication of NO20030989L publication Critical patent/NO20030989L/no
Publication of NO325012B1 publication Critical patent/NO325012B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20030989A 2000-09-04 2003-03-03 4-halogenerte 17-metylensteroider, fremgangsmate for fremstilling derav og farmasoytiske preparater som inneholder disse forbindelsene, og anvendelse av forbindelsene til fremstilling av medikamenter NO325012B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10043846A DE10043846A1 (de) 2000-09-04 2000-09-04 17-Methylensteroide, Verfahren zu deren Herstellung und diese Verbindung enthaltende pharmazeutische Zusammensetzungen
PCT/EP2001/009943 WO2002019971A1 (de) 2000-09-04 2001-08-29 4-halogenierte 17-methylensteroide, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen

Publications (3)

Publication Number Publication Date
NO20030989D0 NO20030989D0 (no) 2003-03-03
NO20030989L true NO20030989L (no) 2003-05-02
NO325012B1 NO325012B1 (no) 2008-01-14

Family

ID=7655148

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030989A NO325012B1 (no) 2000-09-04 2003-03-03 4-halogenerte 17-metylensteroider, fremgangsmate for fremstilling derav og farmasoytiske preparater som inneholder disse forbindelsene, og anvendelse av forbindelsene til fremstilling av medikamenter

Country Status (29)

Country Link
EP (1) EP1423407B1 (no)
JP (1) JP2004513084A (no)
KR (1) KR100530816B1 (no)
CN (1) CN1262560C (no)
AT (1) ATE319733T1 (no)
AU (2) AU2002210470B2 (no)
BG (1) BG107594A (no)
BR (1) BR0113618A (no)
CA (1) CA2421302C (no)
DE (2) DE10043846A1 (no)
DK (1) DK1423407T3 (no)
EA (1) EA006387B1 (no)
EE (1) EE05186B1 (no)
ES (1) ES2260294T3 (no)
HK (1) HK1060135A1 (no)
HR (1) HRP20030256A2 (no)
HU (1) HUP0300936A3 (no)
IL (2) IL154666A0 (no)
ME (1) MEP14408A (no)
MX (1) MXPA03001912A (no)
NO (1) NO325012B1 (no)
NZ (1) NZ524485A (no)
PL (1) PL360669A1 (no)
PT (1) PT1423407E (no)
RS (1) RS50305B (no)
SK (1) SK286757B6 (no)
UA (1) UA74592C2 (no)
WO (1) WO2002019971A1 (no)
ZA (1) ZA200301715B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10141984A1 (de) 2001-08-28 2003-03-20 Jenapharm Gmbh Neue 17-Methylen-4-azasteroide
US7199115B2 (en) 2004-04-19 2007-04-03 Schering Ag 17α-fluorosteroids, pharmaceutical compositions containing 17α-fluorosteroids and a method of making them
EP2055306A1 (de) * 2007-11-05 2009-05-06 Bayer Schering Pharma AG Verwendung eines Gestagens in Kombination mit einem Estrogen und einem oder mehreren pharmazeutisch annehmbaren hilfsstoffen/Trägern zur laktosefreien oralen Kontrazeption

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2611773A (en) * 1951-08-21 1952-09-23 Upjohn Co Estradiol 17-cyclopenetanepropionate
US3146239A (en) * 1957-09-23 1964-08-25 Syntex Corp 4-halo-19-nor-progesterone
US3232960A (en) * 1959-10-08 1966-02-01 Upjohn Co 3-keto-4-fluoro- and 3-keto-4,4-difluorosteroids and process
US3661940A (en) * 1970-04-13 1972-05-09 Sandoz Ag Derivatives of 21-methyl-19-norpregnanes
US4389345A (en) * 1981-10-09 1983-06-21 G.D. Searle & Co. 3-Oxoestra-17-acetonitrile and unsaturated analogs
US5994334A (en) * 1997-02-05 1999-11-30 University Of Maryland Androgen synthesis inhibitors
WO2002000681A1 (en) * 2000-06-27 2002-01-03 Aventis Pharma S.A. 20-fluoro-17(20)-vinyl steroids as inhibitors of c17-20-lyase and 5-alpha reductase

Also Published As

Publication number Publication date
CN1262560C (zh) 2006-07-05
PT1423407E (pt) 2006-07-31
EA200300322A1 (ru) 2003-10-30
BG107594A (bg) 2003-09-30
ES2260294T3 (es) 2006-11-01
DE10043846A1 (de) 2002-04-04
HUP0300936A2 (hu) 2003-11-28
CA2421302A1 (en) 2003-03-03
WO2002019971A9 (de) 2002-08-08
YU16403A (sh) 2006-05-25
KR100530816B1 (ko) 2005-11-25
JP2004513084A (ja) 2004-04-30
ATE319733T1 (de) 2006-03-15
BR0113618A (pt) 2003-07-15
SK2442003A3 (en) 2003-08-05
EA006387B1 (ru) 2005-12-29
HRP20030256A2 (en) 2005-10-31
NZ524485A (en) 2005-11-25
EP1423407A1 (de) 2004-06-02
HK1060135A1 (en) 2004-07-30
NO20030989D0 (no) 2003-03-03
SK286757B6 (sk) 2009-05-07
NO325012B1 (no) 2008-01-14
CN1452628A (zh) 2003-10-29
PL360669A1 (en) 2004-09-20
HUP0300936A3 (en) 2010-01-28
AU1047002A (en) 2002-03-22
EE200300087A (et) 2005-02-15
DK1423407T3 (da) 2006-07-03
DE50109175D1 (de) 2006-05-04
MXPA03001912A (es) 2004-07-08
IL154666A (en) 2008-12-29
EE05186B1 (et) 2009-06-15
KR20030028836A (ko) 2003-04-10
ZA200301715B (en) 2004-08-13
UA74592C2 (en) 2006-01-16
CA2421302C (en) 2007-08-14
IL154666A0 (en) 2003-09-17
RS50305B (sr) 2009-09-08
EP1423407B1 (de) 2006-03-08
WO2002019971A1 (de) 2002-03-14
MEP14408A (en) 2010-06-10
AU2002210470B2 (en) 2006-07-20

Similar Documents

Publication Publication Date Title
MA26843A1 (fr) NOUVELLES COMPOSITIONS ESTRO-PROGESTATIVES TOPIQUES à EFFET SYSTÉMIQUE
UA66861C2 (uk) 2-феніл-1-[4-(2-аміноетокси)бензил]індол в комбінації з естрогенами, способи лікування та продукт для лікування
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
DE60141587D1 (de) Verfahren zur behandlung von erektionsstörungen und steigerung der libido bei männern
WO2002040702A3 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
DE60115274D1 (de) Verwendung von antiprogestinen zur prophylaxe und behandlung von hormonabhängigen erkrankungen
JP2004508317A5 (no)
DE69921130D1 (de) Verfahren und stoffe zur behandlung des prostatakarzinomes
SE0400346D0 (sv) Steroids for cancer treatment
BR0008437A (pt) Inibidores esteróides de sulfatase e métodos parafabricação e uso dos mesmos
SG154323A1 (en) Estrogen replacement therapy
NO20030989D0 (no) 4-halogenerte 17-metylensteroider, fremgangsmåte for fremstilling derav ogfarmasöytiske preparater som inneholder disse forbindelsene
NO984075D0 (no) Kombinasjon av dehydroepiandrosteron og aromatasehemmere og anvendelse av denne kombinasjon for fremstilling av et legemiddel for behandling av en relativ og absolutt androgen mangel hos menn
WO2002074315A8 (de) Pharmazeutische kombinationspräparate enthaltend aromatasehemmer und substanzen mit estrogener wirkung sowie ihre verwendung zur herstellung eines medikaments zur estrogen-ersatz-therapie
MXPA05008347A (es) Composicion que comprende una combinacion de un inhibidor de aromatasa, una progestina y un estrogeno y su uso para el tratamiento de endometriosis.
HUP0101005A2 (hu) Szteroid aromatáz gátlót tartalmazó gyógyszer emlőrák megelőzésére és/vagy kezelésére
RS20050816A (en) Pure d-(17alpha)-13-ethyl-17-hydroxy- 18,19-dinopregn-4-ene- 20-yne-3-one-3e- and-3z-oxime isomers,as well as process for the synthesis of the mixture of isomers and the pure isomers
JPH0733673A (ja) テストステロン−５α−リダクターゼ阻害剤
DE59907558D1 (de) Mittel zur stabilisierung von lebensmitteln und kosmetischen mitteln sowie verfahren zu dessen herstellung
WO2003045971A3 (en) Solvates of 3.beta., 28-diacetoxy-18-oxo-19, 20, 21, 29, 30-pentanorlupan-22-oic acid, processes for their preparation and pharmaceutical compositions thereof
AR032371A1 (es) Uso de antiprogestinas para la profilaxis y el tratamiento de enfermedades dependientes de hormonas
BR0016092A (pt) Composto, uso de um composto kit para contracepção hormonal em um macho, e, método de tratamento
NO20022713D0 (no) 14,15-syklopropansteroider fra 19-norandrostanserien, fremgangsmåte for fremstilling av forbindelsene, og farmasöytiskepreparater som inneholder forbindelsene

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees